ClinicalTrials.Veeva

Menu

Effect of a Liquid Tonic Drink on Post-meal Glucose and Insulin Responses

A

Australian Catholic University (ACU)

Status

Not yet enrolling

Conditions

Overweight or Obese Adults

Treatments

Other: Breakfast meal challenge with tonic drink
Other: Breakfast meal challenge with placebo drink

Study type

Interventional

Funder types

Other

Identifiers

NCT07030010
2025-4309HC

Details and patient eligibility

About

A randomised, double blinded, placebo-controlled crossover design clinical trial conducted at the Mary MacKillop Institute for Health Research (MMIHR, Australian Catholic University) for individuals with overweight/ obesity. This study will measure the postprandial glucose and hormone responses to a high-carbohydrate meal with/ without a liquid tonic drink.

Full description

Twenty individuals living with overweight/ obesity will be invited to attend the university laboratories on 2 separate occasions to participate in a postprandial (meal) challenge. Participants will consume the same high-carbohydrate meal on each visit, with or without a liquid tonic drink. This will be a cross-over design study, where participants will consume a placebo drink on the alternate visit. Participants will remain in the laboratory for 3-hours following the meal with a venous cannula in place, and have blood samples taken at regular timepoints. Blood samples will be analysed for glucose and appetite hormones. Participants will also wear a continuous glucose monitor throughout the period which encapsulates both study trials.

Enrollment

20 estimated patients

Sex

All

Ages

30 to 64 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged ≥30-64 years
  • Body Mass Index (BMI) of ≥27.0 kg/m2

Exclusion criteria

  • younger than 30 or 65 years or older,
  • a BMI less than 27.0 kg/m2,
  • have an allergy to any of the components in the plant-based tonic (see section 6),
  • pregnant or breastfeeding,
  • regularly skipping breakfast (i.e. not consuming breakfast on 5/7 days per week),
  • any diagnosed metabolic (e.g. diabetes), endocrine (e.g. hyperthyroidism), gastrointestinal (e.g. Crohn's) or cardiovascular (e.g. heart failure) abnormalities,
  • on an energy-restricted diet; significant weight fluctuation in the previous 3 months (>5% body weight),
  • high alcohol consumption (>14 units/week) (as per Alcohol Drink Guidelines),
  • medication that is used to treat blood glucose,
  • unable to attend in person testing sessions, or
  • unable or unwilling to provide blood samples.

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

20 participants in 2 patient groups, including a placebo group

Tonic drink
Active Comparator group
Description:
This arm will receive the tonic drink on their first postprandial challenge
Treatment:
Other: Breakfast meal challenge with tonic drink
Placebo drink
Placebo Comparator group
Description:
This arm will receive the placebo drink on their first postprandial challenge
Treatment:
Other: Breakfast meal challenge with placebo drink

Trial contacts and locations

1

Loading...

Central trial contact

Katherine M Roberts-Thomson, PhD; Evelyn Parr, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems